Persephone Biosciences

OverviewSuggest Edit

Persephone Biosciences is a company developing microbial cell therapies for cancer. It combines artificial intelligence and synthetic biology to design biotherapeutic products modulating the metabolism of gut microbes.
TypePrivate
Founded2017
Websitepersephonebiosciences.com

Latest Updates

Employees (est.) (Sept 2021)8(-11%)
Cybersecurity ratingAMore

Persephone Biosciences Financials and Metrics

Summary Metrics

Founding Date

2017

Persephone Biosciences total Funding

$120 k

Persephone Biosciences latest funding size

$120 k

Time since last funding

4 years ago

Persephone Biosciences investors

Persephone Biosciences's latest funding round in January 2018 was reported to be $120 k. In total, Persephone Biosciences has raised $120 k
Show all financial metrics

Persephone Biosciences Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

Persephone Biosciences Online and Social Media Presence

Embed Graph

Persephone Biosciences Frequently Asked Questions

  • When was Persephone Biosciences founded?

    Persephone Biosciences was founded in 2017.

  • How many employees does Persephone Biosciences have?

    Persephone Biosciences has 8 employees.

  • Who are Persephone Biosciences competitors?

    Competitors of Persephone Biosciences include C4 Therapeutics, PDL BioPharma and Bellicum Pharmaceuticals.